The store will not work correctly when cookies are disabled.
6-methoxy-4-(phenylselanyl)-2-(thiophen-2-yl)quinoline
ID: ALA4638059
PubChem CID: 156011390
Max Phase: Preclinical
Molecular Formula: C20H15NOSSe
Molecular Weight: 396.37
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc2nc(-c3cccs3)cc([Se]c3ccccc3)c2c1
Standard InChI: InChI=1S/C20H15NOSSe/c1-22-14-9-10-17-16(12-14)20(24-15-6-3-2-4-7-15)13-18(21-17)19-8-5-11-23-19/h2-13H,1H3
Standard InChI Key: CGVUWPZMECMUOG-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 27 0 0 0 0 0 0 0 0999 V2000
28.9181 -23.3725 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9169 -24.1920 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6250 -24.6010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6232 -22.9636 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3318 -23.3689 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3326 -24.1879 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0411 -24.5949 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7494 -24.1841 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7446 -23.3620 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0355 -22.9586 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.0428 -25.4121 0.0000 Se 0 0 0 0 0 2 0 0 0 0 0 0
31.7513 -25.8193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7497 -26.6341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4574 -27.0411 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1653 -26.6310 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1609 -25.8096 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4526 -25.4063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4498 -22.9491 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2089 -24.6000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.5015 -24.1909 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1975 -23.2745 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7406 -22.6639 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3277 -21.9586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.5295 -22.1335 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
7 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
9 18 1 0
2 19 1 0
19 20 1 0
18 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 18 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 396.37 | Molecular Weight (Monoisotopic): 397.0040 | AlogP: ┄ | #Rotatable Bonds: ┄ |
Polar Surface Area: ┄ | Molecular Species: ┄ | HBA: ┄ | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): ┄ | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: ┄ | CX LogD: ┄ |
Aromatic Rings: ┄ | Heavy Atoms: ┄ | QED Weighted: ┄ | Np Likeness Score: ┄ |
References
1. Costa CA, Lopes RM, Ferraz LS, Esteves GNN, Di Iorio JF, Souza AA, de Oliveira IM, Manarin F, Judice WAS, Stefani HA, Rodrigues T.. (2020) Cytotoxicity of 4-substituted quinoline derivatives: Anticancer and antileishmanial potential., 28 (11): [PMID:32336669] [10.1016/j.bmc.2020.115511] |